non-invasive thigh laxity treatment post-glp-1 therapy GLP-1 Weight Loss & Loose Skin non-invasive thigh laxity treatment post-glp-1

Research indicates that between 50-75% of people stop taking GLP-1 medications within a year, often experiencing weight regain

Ozempic face is a term used to describe facial volume loss that can occur after rapid or significant weight loss, including weight loss associated with GLP-1 medications

These treatments may serve as complementary therapies to surgery or help patients with minimal skin laxity who are not surgical candidates

Patients with significant skin excess following major weight loss will likely be disappointed by non-surgical outcomes alone

Our team includes experienced master artist injectors, and our providers experience spans: Heidi, PA-C (15 years), Alicia, PA-C (10 years), Katie, NP-BC (7 years), Joni, RN (5 years), Tiffany, PA-C (5 years)